Caricamento...
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Nanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer. Nanoparticles can either passively accumulate within tumour sites, or be conjugated with targeting ligands to actively enable tumour deposition. With respect to passive accumulation, particl...
Salvato in:
| Pubblicato in: | Cancer Nanotechnol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Vienna
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276285/ https://ncbi.nlm.nih.gov/pubmed/30595759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12645-018-0044-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|